---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40091915.md"
description: "SciSparc surged over 40% today, driven by policy relaxation in the psychedelic drug treatment field — recent administrative orders have opened up clinical advancement space, creating emotional resonance across the entire sector.However, SciSparc's core pipeline is cannabinoid therapy, which differs from the classic psychedelic drug route. This rally is more due to sector linkage rather than company-specific catalysts.Even after the +40% move, its market cap remains very small with low liquidity. The risk of chasing the rally in the short term is significant. Whether trading volume can continue to expand is the only reference for judging sustainability."
datetime: "2026-04-22T08:53:55.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40091915.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40091915.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40091915.md)
author: "[小仓位过日子](https://longbridge.com/en/profiles/27571747.md)"
---

# SciSparc surged over 40% today, driven by policy r…


### Related Stocks

- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)